Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OptimizeRx Corporation - Common Stock (NQ:OPRX)

20.67 +1.06 (+5.40%)
Streaming Delayed Price Updated: 10:12 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OptimizeRx Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
– AI driven RWD deals grow from 6 completed in 2022 to several dozen in pipeline today, representing the rapid adoption of OptimizeRx’s health technology enablement platform services 
From OptimizeRx Corporation
Via GlobeNewswire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
OptimizeRx Authorizes $15 Million Share Repurchase Program
From OptimizeRx Corporation
Via GlobeNewswire
A Preview Of OptimizeRx's Earnings
 
Via Benzinga
Analyst Ratings for OptimizeRx
Within the last quarter, OptimizeRx (NASDAQ:OPRX) has observed the following analyst ratings: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
Deal will enable high-growth patient services company to streamline and enhance its services with OptimizeRx’s technology solutions 
From OptimizeRx Corporation
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
Earnings Scheduled For March 8, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million. 
Via Benzinga
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx to Participate in Upcoming Investor Conferences
From OptimizeRx Corporation
Via GlobeNewswire
Nasdaq Drops 200 Points; Meta Platforms Shares Jump
U.S. stocks traded lower toward the end of trading , with the Nasdaq Composite dropping 200 points on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
Crude Oil Down Over 2%; Outset Medical Shares Spike Higher
U.S. stocks traded lower midway through trading as investors focused on the outcome of the midterm elections. 
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
OptimizeRx Reports Third Quarter 2022 Financial Results
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
Virtual event takes place December 1, 2022 
From OptimizeRx Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
From OptimizeRx Corporation
Via GlobeNewswire
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution
Analysis demonstrates effectiveness of OptimizeRx’s real-world evidence solution to identify patients suitable for a specialty therapy within a narrow timeframe 
From OptimizeRx Corporation
Via GlobeNewswire
How Is The Market Feeling About OptimizeRx?
OptimizeRx's (NASDAQ:OPRX) short percent of float has fallen 12.86% since its last report. The company recently reported that it has 1.22 million shares sold short,... 
Via Benzinga
Here's How Much $100 Invested In OptimizeRx 5 Years Ago Would Be Worth Today
  OptimizeRx (NASDAQ:OPRX) has outperformed the market over the past 5 years by 54.86% on an annualized basis producing an average annual return of 66.88%. Currently, OptimizeRx has a market... 
Via Benzinga
Nasdaq Surges Over 300 Points; Trade Desk Shares Spike Higher
U.S. stocks traded higher toward the end of trading, following the release of inflation data. 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.